-
1 Comment
Hikal Limited is currently in a long term uptrend where the price is trading 125.8% above its 200 day moving average.
From a valuation standpoint, the stock is 72.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.3.
Hikal Limited's total revenue rose by 14.7% to $5B since the same quarter in the previous year.
Its net income has increased by 42.0% to $403M since the same quarter in the previous year.
Finally, its free cash flow fell by 45.2% to $660M since the same quarter in the previous year.
Based on the above factors, Hikal Limited gets an overall score of 4/5.
CurrencyCode | INR |
---|---|
Industry | Drug Manufacturers-Specialty & Generic |
Sector | Healthcare |
ISIN | INE475B01022 |
Exchange | NSE |
Beta | 1.21 |
---|---|
Dividend Yield | 0.3% |
Target Price | 357.67 |
PE Ratio | 60.35 |
Market Cap | 38B |
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for HIKAL.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024